Press releases

All Press releases are available in Swedish.

September 19, 2016
Regulatory

The US Patent Office has announced its approval of Cyxone's patent on the cyclotide technology.

Read more
August 31, 2016
Regulatory

Cyxone has completed its first toxicity study of drug candidate T20K for the treatment of Multiple Sclerosis (MS) through the LPT Laboratory of Pharmacology and Toxicology GmbH in Germany.

Read more
1
2